Healthcare -
Biotechnology - NASDAQ - US
$ 6.31
3.53 %
$ 742 M
Market Cap
-2.13
P/E
Price Target
Average
248.65%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
26.04%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
89bio, Inc.
Wall Street analysts predict an average 1-year price target for ETNB of $22 , with forecasts ranging from
a
low of
$12 to a high of $29 .
ETNB Lowest Price Target
Wall Street Target
12 USD
90.17%
ETNB Average Price Target
Wall Street Target
22 USD
248.65%
ETNB Highest Price Target
Wall Street Target
29 USD
359.59%
REVENUE FORECAST
Revenue Forecast Chart ETNB
EBIT FORECAST
EBIT Forecast Chart ETNB
NET INCOME FORECAST
Net Income Chart ETNB